1-4 of 4
Carl M. Kirchmaier, MD
Close
Sort by
Journal Articles

Antidotal Effects of rFVIIa and FEIBA on Anticoagulant-Induced Inhibition of Thrombin Generation.

Daniele Pillitteri, MSc, Wolfgang Wegert, MSc, Thomas Scholz, Carl M. Kirchmaier, MD
Journal: Blood
Blood (2006) 108 (11): 4124.
https://doi.org/10.1182/blood.V108.11.4124.4124
Published: 2006
Journal Articles

rFVIIa Treatment and Efficacy Prediction in a Patient with Hermansky-Pudlak Syndrome Type 1 (HPS-1) Using Global Clotting Tests and Flow Cytometry.

Wolfgang Wegert, MSc, Thomas Scholz, Eng., Silke Ehrenforth, MD, Wolfgang Mondorf, MD, Carl M. Kirchmaier, MD
Journal: Blood
Blood (2005) 106 (11): 4019.
https://doi.org/10.1182/blood.V106.11.4019.4019
Published: 2005
Journal Articles

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests.

Steffen Bassus, MD, PhD, Wolfgang Wegert, MS, Manuela Krause, MD, Inge Scharrer, MD, Thomas Scholz, Eng., Carmen Escuriola-Ettinghausen, MD, Annelie Siegemund, MD, Wolfhart Kreuz, MD, Lothar Engelmann, MD, Carl M. Kirchmaier, MD
Journal: Blood
Blood (2004) 104 (11): 3098.
https://doi.org/10.1182/blood.V104.11.3098.3098
Published: 2004
Journal Articles

Factor VIII Efficacy and Tissue Factor Levels in Hemophilia A Patients Undergoing Total Knee Replacement.

Wolfgang Wegert, MS, Manuela Krause, MD, Inge Scharrer, MD, Ulla Stumpf, MD, Andreas Kurth, MD, Steffen Bassus, MD, PhD, Thomas Scholz, Eng., Carl M. Kirchmaier, MD
Journal: Blood
Blood (2004) 104 (11): 4029.
https://doi.org/10.1182/blood.V104.11.4029.4029
Published: 2004